Products & Technologies

Currently, Entest is focused in one area that shows promise for development of an underserved market niche with potentially high demand.

ImenVax.jpg

Entest has developed ImenVax™, a novel immuno-therapeutic cancer vaccine which is used in conjunction with an encapsulation devise that enables the patient’s body to fight and kill cancer cells.

 

Entest BioMedical, Inc. • 4700 Spring Street, Suite 203 • La Mesa, CA • 91942 • Phone: (619) 644-3344 • Fax: (619) 330-2328

Disclaimer